Suven Life Sciences Ltd
NSE:SUVEN

Watchlist Manager
Suven Life Sciences Ltd Logo
Suven Life Sciences Ltd
NSE:SUVEN
Watchlist
Price: 130.92 INR -1.39%
Market Cap: 28.6B INR
Have any thoughts about
Suven Life Sciences Ltd?
Write Note

Relative Value

The Relative Value of one SUVEN stock under the Base Case scenario is 2.2 INR. Compared to the current market price of 130.92 INR, Suven Life Sciences Ltd is Overvalued by 98%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SUVEN Relative Value
Base Case
2.2 INR
Overvaluation 98%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
11
vs Industry
0
Median 3Y
126.8
Median 5Y
100.3
Industry
4.1
vs History
vs Industry
Median 3Y
-11.6
Median 5Y
-11.4
Industry
32.7
vs History
vs Industry
Median 3Y
-12.9
Median 5Y
-12.3
Industry
22.1
vs History
vs Industry
Median 3Y
-12.8
Median 5Y
-12
Industry
33.6
vs History
22
vs Industry
6
Median 3Y
11.7
Median 5Y
9.5
Industry
2.6
vs History
7
vs Industry
1
Median 3Y
122.7
Median 5Y
88.8
Industry
3.9
vs History
vs Industry
2
Median 3Y
65.7
Median 5Y
61
Industry
8.6
vs History
vs Industry
Median 3Y
-10.8
Median 5Y
-10.5
Industry
18.5
vs History
vs Industry
Median 3Y
-10.4
Median 5Y
-10.2
Industry
23.7
vs History
vs Industry
Median 3Y
-11.5
Median 5Y
-11.5
Industry
21.4
vs History
vs Industry
Median 3Y
-10.5
Median 5Y
-10.7
Industry
28.8
vs History
1
vs Industry
0
Median 3Y
16.1
Median 5Y
9.4
Industry
2.4

Multiples Across Competitors

SUVEN Competitors Multiples
Suven Life Sciences Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Suven Life Sciences Ltd
NSE:SUVEN
29B INR 339.3 -19.6 -17.1 -16.5
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 455.6 4 876 1 538.7 3 279.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
202.3B USD 4.8 33 21.4 30.6
US
Danaher Corp
NYSE:DHR
166.6B USD 7.8 42.8 26.9 40.4
KR
Samsung Biologics Co Ltd
KRX:207940
67T KRW 15.4 63.7 34.5 49.6
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.8B USD 6 30.1 22.4 26.1
US
IQVIA Holdings Inc
NYSE:IQV
36.3B USD 2.4 25.8 14.2 21.7
US
Mettler-Toledo International Inc
NYSE:MTD
27B USD 7.2 34 24.3 27.2
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.4 48.3 32.4 40.7
CN
WuXi AppTec Co Ltd
SSE:603259
162B CNY 4.2 20.2 14.6 14.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Suven Life Sciences Ltd
NSE:SUVEN
Average EV/EBITDA: 177.5
Negative Multiple: -17.1
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 538.7
23%
67.6
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.4
19%
1.1
US
Danaher Corp
NYSE:DHR
26.9
22%
1.2
KR
Samsung Biologics Co Ltd
KRX:207940
34.5
57%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
36%
1.2
US
Agilent Technologies Inc
NYSE:A
22.4
34%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
14.2
32%
0.4
US
Mettler-Toledo International Inc
NYSE:MTD
24.3
16%
1.5
US
West Pharmaceutical Services Inc
NYSE:WST
32.4
16%
2
CN
WuXi AppTec Co Ltd
SSE:603259
14.6
52%
0.3

See Also

Discover More
Back to Top